HRTXEarnings•prnewswire•
Heron Therapeutics Announces Q2 2025 Financial Results and Highlights Commercial Progress
Sentiment:Positive (65)
Summary
Generated Q2 2025 Net Revenue of $37.2 million and year-to-date revenue of $76.1 million; reaffirmed 2025 Net Revenue Guidance of $153 million - $163 million Delivered record year-to-date 2025 Adjusted EBITDA of $7.9 million, raised full-year 2025 Adjusted EBITDA Guidance from $4.0...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 8, 2025 by prnewswire